GGrantIndex
Sort

78,016 grants matching breast cancer

Breast and Prostate Cancer Data Quality and Patterns of Care Study

$445,984
Xiaocheng Wu · Lsu Health Sciences Center · U01 · FY2006 · DP

Cancer Mortality among Military Participants at U.S. Nuclear Weapons Tests

$445,972
John Dunning Boice · Vanderbilt University · U01 · FY2014 · CA

MBAT A novel psychosocial cancer intervention

$445,958
Daniel A Monti · Thomas Jefferson University · R01 · FY2009 · CA

REGULATION OF GENE EXPRESSION BY DNA BINDING LIGANDS

$445,957
California Institute Of Technology · R01 · FY2001 · GM

Telephone-Based Genetic Counseling: An Equivalence Trial

$445,945
Georgetown University · R01 · FY2004 · CA

Tissue Engineering Resource Center: TR&D3

$445,884
Gordana Vunjak-Novakovic · Columbia University Health Sciences · P41 · FY2024 · EB

Center of Excellence in Biobehavioral Approaches to Symptom Management

$445,879
Mary Jo E Grap · Virginia Commonwealth University · P30 · FY2012 · NR

Comput. Struct.-Based Design, Chem. Synth., Biochem Charac. and Molec. Mechanism

$445,863
Shaomeng Wang · University Of Michigan At Ann Arbor · U19 · FY2008 · CA

PROTEOGLYCANS AND BASAL LAMINA STRUCTURE/FUNCTION

$445,818
Children'S Hospital Boston · R01 · FY2002 · CA

Microsampling Unit for Capturing Low Abundant Cells

$445,816
Louisiana State Univ A&M Col Baton Rouge · R33 · FY2005 · CA

Role of pharmacogenetics on exemestane metabolism and toxicity

$445,810
Philip Lazarus · Washington State University · R01 · FY2014 · CA

Microfluidic Techniques for the Molecular and Functional Analysis of Gene Express

$445,808
Stephen R Quake · Stanford University · P01 · FY2009 · CA

therapeutic Targeting of CD47 on Human Leukemia and Other Cancer Stem Cells

$445,807
Irving Lerner Weissman · Stanford University · P01 · FY2009 · CA

Senior Leadership

$445,797
Douglas Yee · University Of Minnesota · P30 · FY2011 · CA

Ceramide, Membrane Glycolipids and Glycoprotein Expression

$445,797
Myles C Cabot · Saint John'S Cancer Institute · R01 · FY2008 · GM

Phosphodiesterase 5: A Novel Target and Inhibitor for Breast Cancer Chemopreventi

$445,790
Gary A Piazza · University Of South Alabama · R01 · FY2015 · CA

DIET, EXOGENOUS HORMONES, AND BREAST CANCER RISK

$445,754
Walter C. Willett · Brigham And Women'S Hospital · P01 · FY2008 · CA

Immunometabolic pathways enabled by PARP inhibition in breast cancer

$445,716
Jennifer L. Guerriero · Brigham And Women'S Hospital · R37 · FY2024 · CA

CANCER RISK DETECTION BY MUTATIONAL LOAD DISTRIBUTION AN

$445,696
Yale University · U01 · FY2000 · CA

Eastern Cooperative Oncology Group

$445,682
Lori J Goldstein · Fox Chase Cancer Center · U10 · FY2008 · CA

Eastern Cooperative Oncology Group

$445,682
Lori J Goldstein · Fox Chase Cancer Center · U10 · FY2007 · CA

NRG Oncology NCORP Research Base

$445,671
Deborah W Bruner · Nrg Oncology Foundation, Inc. · UG1 · FY2019 · CA

Translational Control in IPF

$445,667
Peter B Bitterman · University Of Minnesota · R01 · FY2009 · HL

Kin Keeper:Reducing Disparities Through Cancer Literacy and Screening

$445,667
Karen Patricia Williams · Michigan State University · R01 · FY2011 · NR

PI3K Beta regulation of tumor metastasis

$445,640
Anne R Bresnick · Albert Einstein College Of Medicine · P01 · FY2024 · CA